Cargando…
Piloting a generic cancer consumer quality index in six European countries
BACKGROUND: Accounting for patients’ perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to ad...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010728/ https://www.ncbi.nlm.nih.gov/pubmed/27589989 http://dx.doi.org/10.1186/s12885-016-2752-9 |
_version_ | 1782451726695006208 |
---|---|
author | Wind, Anke Roeling, Mark Patrick Heerink, Jana Sixma, Herman Presti, Pietro Lombardo, Claudio van Harten, Wim |
author_facet | Wind, Anke Roeling, Mark Patrick Heerink, Jana Sixma, Herman Presti, Pietro Lombardo, Claudio van Harten, Wim |
author_sort | Wind, Anke |
collection | PubMed |
description | BACKGROUND: Accounting for patients’ perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to adapt and pilot this questionnaire for international comparison of cancer patients experience and satisfaction with care in six European countries. METHOD: The Consumer Quality Index was translated into the local language at the participating pilot sites using cross-translation. A minimum of 100 patients per site were surveyed through convenience sampling. Data from seven pilot sites in six countries was collected through an online and paper-based survey. Internal consistency was tested by calculating Cronbach’s alpha and validity by means of cognitive interviews. Demographic factors were compared as possible influencing factors. RESULTS: A total of 698 patients from six European countries filled the questionnaire. Cronbach’s alpha was good or satisfactory in 8 out of 10 categories. Patient satisfaction significantly differed between the countries. We observed no difference in patient satisfaction for age, gender, education, and tumor type, but satisfaction was significantly higher in patients with a higher level of activation. CONCLUSION: This European Cancer Consumer Quality Index(ECCQI) showed promising scores on internal consistency (reliability) and a good internal validity. The ECCQI is to our knowledge the first to measure and compare experiences and satisfaction of cancer patients on an international level, it may enable healthcare providers to improve the quality of cancer care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2752-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5010728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50107282016-09-04 Piloting a generic cancer consumer quality index in six European countries Wind, Anke Roeling, Mark Patrick Heerink, Jana Sixma, Herman Presti, Pietro Lombardo, Claudio van Harten, Wim BMC Cancer Research Article BACKGROUND: Accounting for patients’ perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to adapt and pilot this questionnaire for international comparison of cancer patients experience and satisfaction with care in six European countries. METHOD: The Consumer Quality Index was translated into the local language at the participating pilot sites using cross-translation. A minimum of 100 patients per site were surveyed through convenience sampling. Data from seven pilot sites in six countries was collected through an online and paper-based survey. Internal consistency was tested by calculating Cronbach’s alpha and validity by means of cognitive interviews. Demographic factors were compared as possible influencing factors. RESULTS: A total of 698 patients from six European countries filled the questionnaire. Cronbach’s alpha was good or satisfactory in 8 out of 10 categories. Patient satisfaction significantly differed between the countries. We observed no difference in patient satisfaction for age, gender, education, and tumor type, but satisfaction was significantly higher in patients with a higher level of activation. CONCLUSION: This European Cancer Consumer Quality Index(ECCQI) showed promising scores on internal consistency (reliability) and a good internal validity. The ECCQI is to our knowledge the first to measure and compare experiences and satisfaction of cancer patients on an international level, it may enable healthcare providers to improve the quality of cancer care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2752-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-02 /pmc/articles/PMC5010728/ /pubmed/27589989 http://dx.doi.org/10.1186/s12885-016-2752-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wind, Anke Roeling, Mark Patrick Heerink, Jana Sixma, Herman Presti, Pietro Lombardo, Claudio van Harten, Wim Piloting a generic cancer consumer quality index in six European countries |
title | Piloting a generic cancer consumer quality index in six European countries |
title_full | Piloting a generic cancer consumer quality index in six European countries |
title_fullStr | Piloting a generic cancer consumer quality index in six European countries |
title_full_unstemmed | Piloting a generic cancer consumer quality index in six European countries |
title_short | Piloting a generic cancer consumer quality index in six European countries |
title_sort | piloting a generic cancer consumer quality index in six european countries |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010728/ https://www.ncbi.nlm.nih.gov/pubmed/27589989 http://dx.doi.org/10.1186/s12885-016-2752-9 |
work_keys_str_mv | AT windanke pilotingagenericcancerconsumerqualityindexinsixeuropeancountries AT roelingmarkpatrick pilotingagenericcancerconsumerqualityindexinsixeuropeancountries AT heerinkjana pilotingagenericcancerconsumerqualityindexinsixeuropeancountries AT sixmaherman pilotingagenericcancerconsumerqualityindexinsixeuropeancountries AT prestipietro pilotingagenericcancerconsumerqualityindexinsixeuropeancountries AT lombardoclaudio pilotingagenericcancerconsumerqualityindexinsixeuropeancountries AT vanhartenwim pilotingagenericcancerconsumerqualityindexinsixeuropeancountries |